These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8231404)

  • 1. [Poisoning by delayed-release verapamil in renal insufficiency patients].
    Daroca Pérez R; Alfaro Olea A; San Román Lazcano FJ; Jiménez Santolaya C
    Med Clin (Barc); 1993 Oct; 101(14):557-8. PubMed ID: 8231404
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute toxic effects of sustained-release verapamil in chronic renal failure.
    Pritza DR; Bierman MH; Hammeke MD
    Arch Intern Med; 1991 Oct; 151(10):2081-4. PubMed ID: 1843183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The toxicity of slow-release verapamil and chronic kidney disease].
    Huelmos A; Alegría E; Vázquez C
    Rev Esp Cardiol; 1994 Nov; 47(11):780. PubMed ID: 7800911
    [No Abstract]   [Full Text] [Related]  

  • 4. [Slow-release verapamil poisoning].
    Rodríguez V; Barriales V; Moris C; Barriales R
    An Med Interna; 1997 Mar; 14(3):159. PubMed ID: 9235094
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of angiotensin converting enzyme inhibitor on renal function in patients of membranoproliferative glomerulonephritis with mild to moderate renal insufficiency.
    Giri S; Mahajan SK; Sen R; Sharma A
    J Assoc Physicians India; 2002 Oct; 50():1245-9. PubMed ID: 12568207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Massive delayed-action verapamil poisoning].
    Hagège A; Masquet C; Beaufils P; Slama R
    Arch Mal Coeur Vaiss; 1990 Oct; 83(11):1745-7. PubMed ID: 2122853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surprisingly delayed escalation of severe verapamil poisoning.
    Tuka V; Ricarova B; Janota T; Malik J; Kotrlikova E
    Eur J Emerg Med; 2009 Apr; 16(2):100-2. PubMed ID: 19194302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of prolonged-action verapamil poisoning].
    Saralegui Reta I; Moreno Ortigosa A; Ochoa Gómez J; Fernández Esteban MV
    Rev Esp Cardiol; 1994 Aug; 47(8):574-5. PubMed ID: 7973021
    [No Abstract]   [Full Text] [Related]  

  • 9. [Fatal poisoning by the retard form of verapamil. Therapeutic considerations].
    Mayer U; Buhl N; Sachs H; Sigel H
    Dtsch Med Wochenschr; 1985 Aug; 110(34):1293-6. PubMed ID: 4028979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Slow-release verapamil poisoning. Use of polyethylene glycol whole-bowel lavage and high-dose calcium.
    Buckley N; Dawson AH; Howarth D; Whyte IM
    Med J Aust; 1993 Feb; 158(3):202-4. PubMed ID: 8450791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of controlled-onset extended-release verapamil in middle-aged and older patients with hypertension and coronary artery disease.
    White WB; Johnson MF; Anders RJ; Elliott WJ; Black HR
    Am Heart J; 2001 Dec; 142(6):1010-5. PubMed ID: 11717605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent data on hypertension and progressive renal disease.
    Zucchelli P; Zuccalà A
    J Hum Hypertens; 1996 Oct; 10(10):679-82. PubMed ID: 9004094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Poisoning by delayed-release verapamil in an uremic patient].
    Robles NR; García Díaz MC; Fernández Mora G; Sánchez Casado E
    Med Clin (Barc); 1992 Dec; 99(19):741-2. PubMed ID: 1460941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overdose of sustained release verapamil.
    Rankin RJ; Edwards IR
    N Z Med J; 1990 Apr; 103(887):165. PubMed ID: 2342687
    [No Abstract]   [Full Text] [Related]  

  • 15. Diabetes, hypertension, and renal insufficiency in post-myocardial infarction cardiovascular risk.
    Abraham WT
    Rev Cardiovasc Med; 2003; 4 Suppl 3():S30-6. PubMed ID: 14564232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Overdose of a drug with delayed action].
    van Wanroy JL; de Weerdt O; Joore JC; van der Hoven B; van de Wiel A
    Ned Tijdschr Geneeskd; 1996 Jan; 140(1):16-8. PubMed ID: 8569903
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of partial liquid ventilation to manage pulmonary complications of acute verapamil-sustained release poisoning.
    Szekely LA; Thompson BT; Woolf A
    J Toxicol Clin Toxicol; 1999; 37(4):475-9. PubMed ID: 10465244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood pressure control and cardiovascular outcomes in high-risk Hispanic patients--findings from the International Verapamil SR/Trandolapril Study (INVEST).
    Cooper-DeHoff RM; Aranda JM; Gaxiola E; Cangiano JL; Garcia-Barreto D; Conti CR; Hewkin A; Pepine CJ;
    Am Heart J; 2006 May; 151(5):1072-9. PubMed ID: 16644338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of the mechanism of regression of left ventricular hypertrophy in hypertension treated with slow-release verapamil].
    Li G; Sun M; Zhou H
    Hunan Yi Ke Da Xue Xue Bao; 1997; 22(5):419-21, 424. PubMed ID: 10073024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of pamidronate in patients with renal failure and hypercalcemia.
    Machado CE; Flombaum CD
    Clin Nephrol; 1996 Mar; 45(3):175-9. PubMed ID: 8706358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.